Results 301 to 310 of about 2,285,924 (374)

Splicing of erythroid transcription factor is associated with therapeutic response in myelodysplastic syndromes. [PDF]

J Clin Invest
Aluri S, Ling T, Fraint E, Chakraborty S, Zhang K, Ahsan A, Kravets L, Poigaialwar G, Zhao R, Pradhan K, Cotton A, Bachiashvili K, Yang JI, Budhathoki A, Agarwal B, Gordon Mitchell S, Carbajal M, Sahu S, Boultwood J, Pellagatti A, Steidl U, Wickrema A, Nandakumar S, Shastri A, Suragani RN, Bowman TV, Crispino JD, Vodala S, Verma A.   +28 more
europepmc   +1 more source

Genome sequencing in the management of myelodysplastic syndromes and related disorders. [PDF]

Haematologica
Cazzola M, Malcovati L.
europepmc   +1 more source

Optimizing Timing and Preparation for Allogeneic Hematopoietic Stem Cell Transplantation in Higher-Risk Myelodysplastic Syndromes. [PDF]

Blood Lymphat Cancer
Geng L, Chen E, Ji Y, Liu H, Sun Z.
europepmc   +1 more source

Understanding infectious complications in patients with lower-risk myelodysplastic syndromes: a step towards improving survival. [PDF]

Haematologica
Garcia-Manero G.
europepmc   +1 more source

Hematopoietic Stem Cell Hierarchies as Novel Biomarkers of Drug Response in Myelodysplastic Syndromes and Acute Myeloid Leukemia. [PDF]

Clin Cancer Res
Ezponda T, Aldaz A, Alfonso-Pierola A, Ganan-Gomez I.   +3 more
europepmc   +1 more source

A correlation of ineffective erythropoiesis and dysregulated signaling pathways in myelodysplastic syndromes/neoplasms. [PDF]

Exp Hematol Oncol
Wu J, Liu J, Chen J, Yang L, Li F, Qin T, Xu Z, Liu J, Zhou J, Shi L, Li B, Xiao Z.   +11 more
europepmc   +1 more source

Correction to "Significance of Mutation Spots and Concurrent Gene Mutations on Prognosis and Clinical Outcomes in Myelodysplastic Syndromes with SF3B1 Mutation". [PDF]

Cancer Med
europepmc   +1 more source

A Scoping Review on Cognition in Myelodysplastic Syndromes: Advances and Challenges. [PDF]

Med Sci (Basel)
Tsiakiri A, Frigkas K, Vlotinou P, Papoutselis M, Christidi F, Karavasilis E, Kotsianidis I, Kourkoutsakis N, Vadikolias K, Liapis K.   +9 more
europepmc   +1 more source

Molecular characteristics and clinical implications of TP53 mutations in therapy-related myelodysplastic syndromes. [PDF]

Blood Cancer J
Bao Z, Li B, Qin T, Xu Z, Qu S, Jia Y, Li C, Pan L, Gao Q, Jiao M, Wang H, Sun Q, Xiao Z.   +12 more
europepmc   +1 more source